Eco-friendly HPTLC method for Trifluridine and Tipiracil determination: Quality-by-design meets green analytical chemistry
Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide, necessitating efficient treatment strategies and accurate analytical methods. This study presents a green analytical approach using a Quality by Design (QbD)-assisted high-performance thin-layer chromatography (HPTLC)...
Saved in:
| Main Authors: | Amruta Balekundri, Eknath D. Ahire, Rakesh U. Shelke, Dinesh D. Rishipathak, Sanjay J. Kshirsagar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Green Analytical Chemistry |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772577425000308 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients
by: Toshiaki Takahashi, et al.
Published: (2025-01-01) -
Real-World Comparison of Trifluridine–Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer
by: Hyunho Kim, et al.
Published: (2025-04-01) -
Brazilian cohort results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer
by: Celso Abdon Lopes de Mello, et al.
Published: (2022-12-01) -
Trifluridine- and tipiracil-induced DPD inhibition mimicking DPD deficiency: a case report
by: Antonin Schmitt, et al.
Published: (2025-08-01) -
Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trialResearch in context
by: Niels A.D. Guchelaar, et al.
Published: (2025-02-01)